Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 08, 2021 08:09 ET | Source: AntiMatter

AntiMatter Perpetrual Options Launches on ETH, Arbitrum, AVAX, Terra, BSC, & More

Singapore, Oct. 08, 2021 (GLOBE NEWSWIRE) -- AntiMatter is the first non-oracle DeFi derivative trading platform. Users are able to generate their own auto-self-pricing derivative products, such as...
October 07, 2021 09:00 ET | Source: The Apache Software Foundation

The Apache Software Foundation Announces Apache® OpenOffice® 4.1.11

Wilmington, DE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The Apache Software Foundation Announces Apache® OpenOffice® 4.1.11 Updates to security and availability of leading Open Source office document...
October 07, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel

Technology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than...
October 06, 2021 07:36 ET | Source: Altbase

Altbase Token to Launch Oct 12

AUCKLAND, New Zealand, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Today it has been announced that Altbase Token ($ALTB) will officially launch on the Binance Smart Chain (BSC) at 12 PM PST on October 12th....
September 30, 2021 12:30 ET | Source: OSE Immunotherapeutics

Boehringer Ingelheim and OSE Immunotherapeutics Announce First Patient Dosed in Phase 1 Expansion Trial of SIRPα Antagonist Monoclonal Antibody BI 765063 in combination with anti-PD-1 Antibody Ezabenlimab, in Patients with Advanced Endometrium or Colorectal Tumors

Dosing of first patient in the expansion phase triggers a milestone payment of €8 million from Boehringer Ingelheim to OSE Immunotherapeutics.Data from the dose escalation Step 1 of the Phase 1 trial...
September 29, 2021 09:00 ET | Source: Cirrus Link Solutions

Cirrus Link Announces Issuance of U.S. Patent for Chariot V2

KANSAS CITY, Kan., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Cirrus Link today announced the company has received a US Patent for the Chariot V2 MQTT Server, the first to market to be Sparkplug-aware for...
September 23, 2021 10:00 ET | Source: Verified Market Research

Hyperbaric Oxygen Therapy Market size worth $ 4.79 Billion, Globally, by 2028 at 6.24% CAGR: Verified Market Research®

Jersey City, New Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Hyperbaric Oxygen Therapy Market” By Product Type (Monoplace HBOT, Topical HBOT,...
September 21, 2021 18:48 ET | Source: First Watch

First Watch Opens in Richmond, TX

RICHMOND, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) -- First Watch restaurant opened Monday at 10505 West Grand Parkway, Ste. 100, Richmond, TX, brunch fans in Fort Bend County will notice some...
September 20, 2021 12:00 ET | Source: Snapt

Snapt to Present Nova V2 at Nutanix .NEXT Digital Experience

SAN JOSE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Snapt, a Nutanix partner, announced today that it will host a booth at Nutanix's Global .NEXT Digital Experience conference to present Nova V2,...
September 17, 2021 07:02 ET | Source: Gritstone bio, Inc.

Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE “Off-the-Shelf” Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical Trial

SLATE version (v) 1, Gritstone’s “off the-shelf" neoantigen immunotherapy (including KRAS, TP53 mutations), elicited multiple molecular responses and an unconfirmed RECIST radiologic response in...